Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Treatment Approach Gives Patients With Incurable Lung Cancer More Time Without Disease Progression Compared To Placebo
Results from a Phase III study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida today show that patients with advanced non-small cell lung cancer (NSCLC) who received erlotinib (Tarceva®) as first-line maintenance treatment benefited from a significant (29%) improvement in the time they lived without the disease advancing, compared with those who received placebo1. Patients in the global multicentre SATURN trial, which included patients from the UK, received maintenance treatment with erlotinib if their cancer had not progressed on initial chemotherapy. The data showed a significant improvement in the length of time patients lived without their disease getting worse, and without the need for further chemotherapy. 1 The improvement was seen in both of the main types of NSCLC (squamous cell as well as non-squamous cell) and these results form the basis of a submission for regulatory approval of erlotinib to be used in the first-line maintenance setting. 1 Erlotinib is not currently licensed for first line maintenance treatment in NSCLC lung cancer in the UK.
generic viagra online
Iron-Binding Drug Could Help Diabetics Heal Stubborn Wounds, Says Stanford/Einstein Study
A drug used to remove iron from the body could help doctors fight one of diabetes" cruelest complications: poor wound healing, which can lead to amputation of patients" toes, feet and even legs.
News of the day
Olanzapine Long-Acting Injection (LAI) Efficacy And Safety Data Presented At American Psychiatric Association Annual Meeting
Eli Lilly and Company presented data on the short- and long-term efficacy and safety of olanzapine long-acting injection (LAI) in the treatment of adults with schizophrenia or schizoaffective disorder. Olanzapine LAI is an investigational formulation that combines the atypical antipsychotic Zyprexa(R) (olanzapine) with pamoic acid, allowing for the sustained delivery of olanzapine for up to four weeks.
Health Insurance

Liverpool To Strengthen Health Research In Africa

Researchers at the Liverpool School of Tropical Medicine (LSTM) and the University of Liverpool will work with universities across Africa as part of a ÷£30 million initiative to strengthen research into science and health on the continent. The Wellcome Trust initiative will see the formation of seven new international consortiums that will focus on developing and sustaining high quality research into the health and wellbeing of African people. More than 50 institutions from 18 African countries will participate in the programme and lead on partnerships with scientists from Europe, the US and Australia. Africa is affected by some of the world"s deadliest diseases, including HIV, malaria and tuberculosis. Many African universities need help to drive forward research into these conditions and nurture young researchers at the beginning of their careers. LSTM and the University work with universities in South Africa, Botswana, Zambia, Malawi and Zimbabwe as part of the SACORE consortium which aims to support African medical schools in creating a vibrant research environment for students and research leaders. The collaboration will also help create postgraduate scholarships to allow students to research health-related issues in their home country. Professor Peter Winstanley, from Liverpool"s Wellcome Trust Tropical Centre, said: "This initiative is built on 20 years of University and LSTM collaboration and shows the major impact that such global networks can have. Within the SACORE consortium we will create a joint Malawi-Liverpool PhD programme as part of our contribution to the training of biomedical researchers in a region that needs excellent science to underpin developments in healthcare. "The most pressing problems in Africa right now are infectious diseases. Falciparum malaria remains one of the highest priorities in children. In adults HIV-related pathogens, such as TB and Salmonellae, demand the most attention. This new initiative will improve the capacity of African medical schools to develop research careers and secure essential funding for long-term commitment to studies in health sciences." Alan Hughes Liverpool School of Tropical Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009